Grignani F[Author] - Search Results

Year	Number of Results
1955	5
1956	4
1957	4
1958	6
1959	5
1960	5
1961	1
1962	4
1963	6
1964	4
1965	8
1966	2
1967	6
1972	1
1973	1
1974	5
1976	1
1978	1
1979	2
1980	3
1981	2
1982	3
1983	5
1984	3
1985	6
1986	9
1987	6
1988	12
1989	9
1990	14
1991	10
1992	12
1993	15
1994	7
1995	6
1996	8
1997	7
1998	12
1999	8
2000	1
2003	1
2004	2
2005	1
2006	1
2007	4
2008	4
2009	1
2011	1
2012	2
2013	3
2014	3
2015	3
2016	3
2018	1
2019	1
2020	2
2021	0

1

Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1-dependent mechanism.

Ceccarelli V, Valentini V, Ronchetti S, Cannarile L, Billi M, Riccardi C, Ottini L, Talesa VN, Grignani F, Vecchini A. Ceccarelli V, et al. Among authors: grignani f. FASEB J. 2018 May 14:fj201800245R. doi: 10.1096/fj.201800245R. Online ahead of print. FASEB J. 2018. PMID: 29757674

2

RARs and microRNAs.

Nervi C, Grignani F. Nervi C, et al. Among authors: grignani f. Subcell Biochem. 2014;70:151-79. doi: 10.1007/978-94-017-9050-5_8. Subcell Biochem. 2014. PMID: 24962885 Review.

3

Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.

Quattrocchi A, Maiorca C, Billi M, Tomassini S, De Marinis E, Cenfra N, Equitani F, Gentile M, Ceccherelli A, Banella C, Mecarocci S, Scerpa MC, Pisanò S, Pacilli A, Di Cristofano C, Mancini M, Guglielmelli P, Vannucchi AM, Noguera N, Grignani F, Cimino G, Nervi C. Quattrocchi A, et al. Among authors: grignani f. Am J Hematol. 2020 Jun 22. doi: 10.1002/ajh.25911. Online ahead of print. Am J Hematol. 2020. PMID: 32572989 No abstract available.

4

Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.

Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F. Ulivi P, et al. Among authors: grignani f. J Clin Med. 2019 Jan 23;8(2):131. doi: 10.3390/jcm8020131. J Clin Med. 2019. PMID: 30678026 Free PMC article.

5

Chronic myelogenous leukemia.

Grignani F. Grignani F. Crit Rev Oncol Hematol. 1985;4(1):31-66. Crit Rev Oncol Hematol. 1985. PMID: 3902263 Review.

6

Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.

Ceccarelli V, Ronchetti S, Marchetti MC, Calvitti M, Riccardi C, Grignani F, Vecchini A. Ceccarelli V, et al. Among authors: grignani f. Biochim Biophys Acta Gene Regul Mech. 2020 Feb;1863(2):194481. doi: 10.1016/j.bbagrm.2020.194481. Epub 2020 Jan 8. Biochim Biophys Acta Gene Regul Mech. 2020. PMID: 31923609

7

Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications.

Ricciuti B, Leonardi GC, Metro G, Grignani F, Paglialunga L, Bellezza G, Baglivo S, Mencaroni C, Baldi A, Zicari D, Crinò L. Ricciuti B, et al. Among authors: grignani f. Expert Rev Respir Med. 2016;10(1):53-68. doi: 10.1586/17476348.2016.1115349. Epub 2015 Nov 17. Expert Rev Respir Med. 2016. PMID: 26714748 Review.

8

Acute promyelocytic leukemia: from genetics to treatment.

Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG. Grignani F, et al. Blood. 1994 Jan 1;83(1):10-25. Blood. 1994. PMID: 8274729 Review. No abstract available.

9

Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis.

Nervi C, Fazi F, Grignani F. Nervi C, et al. Among authors: grignani f. Epigenetics. 2008 Jan-Feb;3(1):1-4. doi: 10.4161/epi.3.1.5651. Epigenetics. 2008. PMID: 18416028 Review.

10

The molecular genetics of acute promyelocytic leukemia.

Grignani F, Fagioli M, Ferrucci PF, Alcalay M, Pelicci PG. Grignani F, et al. Blood Rev. 1993 Jun;7(2):87-93. doi: 10.1016/s0268-960x(05)80018-9. Blood Rev. 1993. PMID: 8396481 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results